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Abstract The Y-box binding protein, YB-1, is a member of a 
DNA binding protein family with a structurally and functionally 
conserved cold shock domain. Using Western blotting and 
immunohistochemical methods, larger amounts of YB-1 were 
detected in the cytosol, particularly at the perinuclear region, 
than in the nucleus of human cancer cells. UV irradiation 
increased accumulation of YB-1 in the nucleus at 20 min and 
thereafter. This translocation of YB-1 into the nucleus by UV 
irradiation was blocked by the protein kinase inhibitor H-7, but 
not HA-1004. Both green fluorescent protein (GFP)-YB-l and 
GFP-YB-1C with the C-terminus (248-317) of YB-1 were 
located mainly in the cytosol, but GFP-YB-1AC with a deletion 
at the C-terminus of YB-1 was located in the nucleus. YB-1 is 
translocated into the nucleus by UV irradiation, possibly through 
a protein kinase C-mediated signal transduction pathway, and 
the C-terminal region of YB-1 might be important for 
cytoplasmic retention of YB-1. 
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1. Introduction 
The human protein, YB-1, belongs to the Y-box binding 
protein family. Each of these proteins has been shown to 
posses three principal domains. The N-terminal domain, 
which is rich in proline and alanine, is thought to function 
as a transcriptional regulation domain [1,2]. The middle por-
tion, termed the nucleic acid binding domain or cold shock 
domain (CSD), binds to the Y-box, an inverted CCAAT box, 
in the promoter region of many genes; this domain is highly 
conserved in evolution [1,3,4]. Finally, the C-terminal region, 
also termed the charged zipper domain, contains alternating 
positively and negatively charged regions and has been impli-
cated in protein-protein interactions [1,2,5]. 
YB-1 was initially cloned by screening a human B-cell ex-
pression library for proteins that interact with the Y-box in 
the promoter region of major histocompatibility complex class 
II genes [6]. The YB-1 protein has been shown to bind to 
single-stranded DNA sequences, damaged DNA, and RNA 
[1,3,7]. Binding of YB-1 to its consensus sequence has been 
shown to be enhanced in response to UV irradiation and 
chemical agents [8-10]. The YB-1 gene product, which is ubiq-
uitous in many human tissues, is overexpressed in human 
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cancer cell lines resistant to cisplatin, a platinum-containing 
anticancer drug that has been shown to damage cell DNA 
[11]. Transfection of YB-1 antisense oligonucleotides into cells 
confers an increased sensitivity to cisplatin as well as to mi-
tomycin C and UV irradiation [11]. 
The Y-box consensus sequence has been found to be 
present in the promoter region of many genes. Genes that 
include this sequence in their c/.y-regulatory element include 
those encoding thymidine kinase, proliferating cell nuclear 
antigen, DNA polymerase a, epidermal growth factor recep-
tor [1,3,4], as well as multidrug resistance 1 (MDR1) [12]. 
We have previously shown that the inverted CCAAT box in 
the human MDR1 gene promoter is required for promoter 
activation by various environmental stimuli including carcino-
gens, anticancer agents, and UV irradiation [8-10,13-15]. We 
therefore hypothesized that MDR1 is a stress-induced gene, 
activated by the binding of the nuclear protein, MDR-NF1, to 
the MDR1 promoter region [16]. We previously cloned the 
MDR-NF1 cDNA from a human colon library and showed 
that it is identical to YB-1 cDNA [11,17]. This enhanced ex-
pression of the human MDR1 gene in response to DNA dam-
aging agents may be due to the enhanced binding of YB-1 to 
the inverted CCAAT box (Y-box) consensus sequence on the 
MDR1 promoter [8-10]. Bargou and colleagues have recently 
reported that nuclear localization and an increased level of 
YB-1 are closely associated with intrinsic MDR1 gene expres-
sion in primary human breast cancers [18]. 
The further analysis of the intracellular state or localization 
of YB-1 should be critical to understand how MDR1 gene 
promoter and other Y-box-containing promoters are activated 
in response to UV irradiation or other genotoxic stimuli. 
2. Materials and methods 
2.1. Materials 
Propidium iodide was purchased from Sigma (Tokyo, Japan). H-7 
(1 -(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride) and 
HA-1004 (/V-(2-guanidinoethyl)-5-isoquinolinesulfonamide dihydro-
chloride) were purchased from Biomol Research Laboratories, Inc. 
(Plymouth Meeting, PA, USA). 
2.2. Antibodies 
Polyclonal anti-YBC antibodies to YB-1 were prepared against a 
15-amino acid peptide (residues 299-313) (Fig. 3A) [11]. Monoclonal 
antibodies to DNA topoisomerase Ila were prepared as described 
previously [19]. 
2.3. Cell culture 
A line of human epidermoid cancer cells, KB, were grown in mono-
layer culture in Eagle's minimum essential medium (Nissui Seiyaku 
Co., Tokyo, Japan) containing 10% newborn calf serum (Sera-lab 
Ltd., Sussex, UK), 292 ug/ml glutamine, 100 ug/ml kanamycin, and 
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100 units/ml penicillin at 37°C in a humidified atmosphere of 5% C 0 2 
[20]. 
2.4. Subcellular fractionation 
Cells were harvested, suspended in four packed cell volumes of 
buffer A (10 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 mM KC1, 
0.5 mM PMSF, 0.5 mM DTT) for 20 min, and homogenized by 20 
strokes with a loose-fitting Dounce homogenizer. The nuclear pellets 
were collected by centrifugation for 6 min at 4300 X g, resuspended in 
five volumes of buffer A, and washed once by centrifugation. Proteins 
were extracted from the washed nuclei with high salt, followed by 
centrifugation of the nuclear extracts and dialysis against buffer D 
(20 mM HEPES (pH 7.9), 20% (v/v) glycerol, 0.1 M KC1, 0.2 mM 
EDTA, 0.5 mM PMSF, 0.5 mM DTT). 1% NP-40 (v/v) was added to 
the dialyzed nuclear extracts. The postnuclear fractions referred to the 
cytosolic fraction was adjusted to buffer D containing 1% (v/v) NP-40 
conditions by the addition of stock solutions. Insoluble material was 
removed by centrifugation for 15 min in a Microfuge. Samples were 
stored at -80°C [21]. 
2.5. Western blot analysis 
Western blots were performed as described previously [11]. Mem-
branes were developed by chemiluminescence following the ECL pro-
tocol (Amersham). 
2.6. Indirect immunofluorescence 
Cells grown on coverslips were washed twice with cold phosphate-
buffered saline (PBS), fixed with methanol for 15 min at —20°C, and 
rinsed with PBS. Cells were permeabilized with PBS-T (PBS contain-
ing 0.1% Triton X-100) for 30 min and then incubated for 1 h with 
rabbit anti-YBC antibodies diluted 1:500 in PBS-T. After washing 
with PBS-T, cells were incubated for 45 min with FITC-conjugated 
goat anti-rabbit IgG (Organon Teknika N.V., Turnhout, Belgium) 
diluted 1:100 in PBS-T. The cells were subsequently washed with 
PBS-T followed by PBS. Coverslips were mounted with 50% glycerol 
in PBS. The cell nuclei were stained with propidium iodide (200 ng/ 
ml). The samples were examined by Nikon fluorescence microscopy 
with a Bio-Rad MRC1000 laser scanning confocal imaging system 
[22]. 
2.7. Construction of the green fluorescent protein (GFP)-YB-l 
To obtain the GFP fusion construct for the expression of full-length 
YB-1 protein (GFP-YB-1), the plasmid pRc/CMV, into which was 
inserted a full-length YB-1 cDNA, was digested with ffindlll to re-
move the insert. The YB-1 cDNA was subcloned into the Hin&Wl site 
of the pEGFP-Cl expression vctor. (Clontech, Palo Alto, CA, USA). 
To obtain a construct expressing YB-1 from which the C-terminal 
domain had been deleted (GFP-YB-1AC), GFP-YB-1 expression plas-
mids were digested with Sail to remove the C-terminal region of YB-
1. To obtain a construct expressing YB-1 which had the C-terminal 
domain (GFP-YB-1C), GFP-YB-1 expression plasmids were digested 
with Apal to obtain the C-terminal region of YB-1, and this cDNA 
was subcloned into the Apal site of the pEGFP-Cl expression vector. 
2.8. Transfection and confocal analysis 
COS-7 cells and the human bladder cancer T24 cells were main-
tained in DMEM with 10% FBS at 37°C in a 5% C0 2 atmosphere. 
Cells were plated on glass coverslips at a density of 2X104 cells/cm2 
the night before transfection. Transfection was performed using Lip-
ofectin (Gibco BRL, Bethesda, MD, USA) according to the manufac-
turer's protocol. Cells were incubated for 48 h following application 
of DNA. For confocal analysis, cells were washed with PBS twice, 
fixed in PBS containing 4%> freshly prepared paraformaldehyde, and 
washed with PBS twice. Alternatively, coverslips were mounted di-
rectly on slides for observation. The samples were examined by Nikon 
fluorescence microscopy with a Bio-Rad MRC1000 laser scanning 
confocal imaging system [22]. 
3. Results and discussion 
Treatment of cells with UV irradiation or drugs has been 
shown to induce binding of YB-1 to its Y-box [8-10]. We 
examined whether the cellular level of YB-1 was increased 
in response to UV irradiation in KB cells. Western blot anal-
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Fig. 1. Subcellular distribution of YB-1 and the effect of UV irradi-
ation. A: Whole cell lysates of control untreated KB cells (indicated 
as 0 min) and cells exposed to UV irradiation (40 J/m2) for the in-
dicated time were assayed by immunoblotting using anti-YB-1 anti-
bodies. Each lane contains 20 ug of total protein. The control top-
ol la was also immunoblotted. B: Both nuclear extracts (N) and 
cytosolic fractions (C) of control untreated KB cells (indicated as 0 
min) and cells exposed to UV irradiation (40 J/m2) for the indicated 
time were assayed by immunoblotting using anti-YBC. Each lane 
contains 20 ug of total protein. The control topolla was also im-
munoblotted. C: Untreated KB cells and cells 1 h after UV (40 J/ 
m2) irradiation were stained with anti-YB-1 antibodies (YB-1) and 
viewed with a confocal laser scanning microscope. The nuclei were 
stained with propidium iodide (PI). 
ysis with anti-YBC antibodies showed no change of the cel-
lular level of YB-1 until 6 h after UV irradiation (Fig. 1A). 
DNA topoisomerase I la (topolla), a nuclear enzyme, also 
showed no change in its levels after UV irradiation (Fig. 
1A). We next examined if the level of YB-1 was altered in 
the nucleus after UV irradiation. Western blot analysis 
showed that there was about 10 times more YB-1 in the cy-
tosol than in the nuclear fraction (Fig. IB). Increased 
amounts of YB-1 in the nucleus were observed 20 min after 
UV irradiation (Fig. IB). A higher level of YB-1 was main-
tained up to 3 h in the nucleus after UV irradiation. By con-
trast, topolla showed no change in its levels in the nuclear 
fraction after UV irradiation. Topolla could not be detected 
in the cytosol fraction, indicating that the cytosol fraction was 
not contaminated with nuclear protein (Fig. IB). The subcel-
lular distribution of YB-1 in KB cells was also examined by 
indirect immunofluorescence microscopy. For comparison, the 
cells were also stained with propidium iodide which specifi-
cally stained the nuclei. The image of cells stained with anti-
YBC antibody and propidium iodide showed that YB-1 was 
localized mainly in the perinuclear region (Fig. 1C). Consis-
tent with this result, dbpA, a member of the YB-1 family, was 
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Fig. 2. Effect of protein kinase inhibitors on the nuclear accumulation of YB-1 induced by UV irradiation. A: H-7 and HA-1004 were added 
to cell cultures at 40 u,M 90 min before UV irradiation, nuclear extracts of control untreated KB cells and cells 1 h after UV irradiation (40 31 
m2) were assayed by immunoblotting with anti-YB-1 antibodies. Each lane contains 20 ug of total protein. The control topolla was also im-
munoblotted. B: H-7 and HA-1004 were added to cell cultures at 40 uM 90 min before UV irradiation, control untreated KB cells and cells 
1 h after UV irradiation (40 J/m2) were immunostained by anti-YB-1 antibodies (YB-1) and viewed with a confocal laser scanning microscope. 
The nuclei were stained with propidium iodide (PI). 
mostly located in the cytoplasm, particularly at the perinu-
clear region in human cancer cells [23]. Immunofluorescence 
data also showed an apparent increase of YB-1 in the nucleus 
of cells 1 h after UV irradiation (Fig. 1C). These results in-
dicate that the nuclear translocation of the YB-1 was induced 
by UV irradiation. 
The import of transcription factors into the nucleus is not a 
constitutive process, and appears to be modulated in response 
to external stimuli, cell cycle and development. Regulation of 
the subcellular localization of proteins involves the direct 
phosphorylation of the transported protein, masking of the 
nuclear localization signal(s), cytoplasmic retention by bind-
ing to an anchoring protein, and the interplay among these 
different mechanisms [24-26]. We previously reported that 
transcriptional activation of the MDR1 gene by UV irradia-
tion is mediated through the Y-box motif [8,9]. This YB-1-
mediated activation of the MDR1 promoter, however, is al-
most completely abrogated by a high concentration of the 
protein kinase C inhibitor H-7 [8,27], which suggests the pos-
sible involvement of the protein kinase in the nuclear trans-
location of YB-1. We examined the effect of protein kinase 
inhibitors, H-7 and HA-1004, on the nuclear translocation of 
YB-1 after UV irradiation. H-7 and HA-1004 inhibit a variety 
of protein kinases with distinct K\ values, but H-7 inhibits 
protein kinase C in comparison with HA-1004 [28,29]. Immu-
noblot analysis of nuclear protein showed that H-7 at 40 \\M 
inhibited the nuclear translocation of YB-1 after UV irradi-
ation, but not HA-1004 (Fig. 2A). Indirect immunofluores-
cence also showed that H-7, but not HA-1004, inhibited the 
nuclear translocation of YB-1 after UV irradiation (Fig. 2B). 
These results suggest that protein kinase C might specifically 
modulate the nuclear translocation of YB-1 induced by UV 
irradiation. 
YB-1 does not have consensus sequence for the transloca-
tion of proteins to the nucleus, but it does have putative 
nuclear localization signals that consist of a cluster of three 
to six basic residues in a short peptide of four to nine amino 
acids [30]. YB-1 contains at least six such sequences of amino 
acids: 150-152, 185-192, 199-205, 242-247, 279-283, and 
288-291, in a region of alternating blocks of predominantly 
acidic and basic amino acids (Fig. 3A). Moreover, YB-1 was 
mainly located in the cytoplasm. To assess which domain is 
important for cytoplasmic retention of YB-1, we generated 
plasmid constructs containing full-length YB-1 and its trun-
cated form YB-1AC and YB-1C linked to GFP (Fig. 3B). 
Human bladder cancer T24 cells were transfected with GFP-
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Fig. 3. Schematic representation of the YB-1 and GFP-YB-1 fusion 
proteins. A: Schematic drawing of the YB-1 and the position of the 
synthetic peptide used to prepare polyclonal antibodies to anti-
YBC. The highly conserved CSD is the nucleic acid recognition do-
main. The N-terminal domain is involved in transcriptional regula-
tion. The C-terminal domain, including the alternating basic/acidic 
amino acid cluster, is involved in protein-protein interactions. +, ba-
sic amino acids; —, acidic amino acids. B: Diagrams of the prod-
ucts of the GFP-YB-1 and its deletion constructs used in this study. 
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YB-1 plasmid, and treated with UV (40 J/m2). GFP-YB-1 
protein was mainly located in the perinuclear region of un-
treated cells (Fig. 4). By contrast, translocation of GFP-YB-1 
was apparently observed 1 h after UV irradiation (Fig. 4). 
Endogenous YB-1 as well as exogenous YB-1 (GFP-YB-1) 
thus appeared to be accumulated in the nucleus under UV 
irradiation. 
We further transfected GFP-YB-1 and its deletion con-
structs (GFP-YB-1 AC and GFP-YB-1 C) into COS-7 cells, 
and examined which domain in the YB-1 was critical for 
the cytoplasmic retention. The GFP-YB-1 protein as well as 
GFP-YB-1 C were mainly located in the perinuclear region 
(Fig. 5B,D). By contrast, GFP-YB-1AC was mainly localized 
in the nucleus (Fig. 5C). GFP alone was localized in both 
cytoplasm and nucleus (Fig. 5A). The C-terminal domain 
might be important for the cytoplasmic retention or nuclear 
export of YB-1. However, the C-terminal domain does not 
have a nuclear export signal such as mitogen-activated protein 
kinase kinase [31]. Since this domain has been shown to be 
involved in the protein-protein interaction [1,2,5], we hypothe-
sized that YB-1 could be retained in the cytoplasm by binding 
to an anchoring protein as observed in the representative tran-
scription factor N F - K B interacting with IKB in the cytoplasm 
[32]. Using glutathione S-transferase (GST)-YB-l, affinity pu-
rification of such proteins associated with the C-terminal do-
main of YB-1 is now in progress. 
We have previously reported that transfection of the YB-1 
antisense oligonucleotides into cells resulted in their increased 
sensitivity to the cytotoxic effects of cisplatin, mitomycin C 
and UV irradiation, suggesting that YB-1 itself protects the 
cells against the effects of this genotoxic damage [11]. The Y-
box proteins are integral components of a eukaryotic redox 
signaling pathway, serving as a scaffold for the assembly of 
other factors [33], suggesting that these Y-box proteins may 
be part of a mammalian stress signal transduction mechanism 
[34]. These studies indicate that YB-1 may itself have a key 
role in self-defense signaling mechanisms, being initiated in 
response to such environmental poisons as oxidative stress 
or DNA damaging reagents. Bargou et al. have recently re-
ported that nuclear localization of YB-1 is closely associated 
with intrinsic MDR1 gene expression in primary human 
breast cancers [18]. Further study is required to determine 
whether MDR1 gene overexpression is closely associated 
with YB-1 activities in human breast cancers and other hu-
man tumors in the absence or presence of environmental 
stress. 
UV 
Fig. 4. Subcellular distribution of GFP-YB-1 and the effect of UV 
irradiation. Human bladder cancer T24 cells were transiently trans-
fected with GFP-YB-1. Untreated cells and cells 1 h after UV (40 J/ 
m2) irradiation were analyzed by confocal microscopy. 
Fig. 5. Subcellular distribution of GFP, GFP-YB-1, GFP-YB-1AC 
and GFP-YB-1C. COS-7 cells was transiently transfected with GFP 
(A), GFP-YB-1 (B), GFP-YB-1AC (C), or GFP-YB-1C (D), and an-
alyzed by confocal microscopy. 
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